Literature DB >> 476647

A clinical-pharmacological evaluation of hepatic arterial infusion of adriamycin.

M B Garnick, W D Ensminger, M Israel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 476647

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  19 in total

1.  Primary hepatocellular carcinoma--recent advances and future prospects.

Authors: 
Journal:  West J Med       Date:  1985-10

2.  A pharmacokinetic study of adriamycin and 4'epi-adriamycin after simultaneous intra-arterial liver administration.

Authors:  S Eksborg; M Andersson; L Domellöf; U Lönroth
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

Review 3.  The role of chemotherapy in the treatment of bile duct cancer.

Authors:  R A Oberfield; R L Rossi
Journal:  World J Surg       Date:  1988-02       Impact factor: 3.352

Review 4.  Dose-dependent pharmacokinetics and cancer chemotherapy.

Authors:  G Powis; M M Ames; J S Kovach
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

5.  Chronopharmacokinetics of doxorubicin in patients with breast cancer.

Authors:  P Canal; A Sqall; M de Forni; C Chevreau; A Pujol; R Bugat; H Roche; J Oustrin; G Houin
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

6.  Intrahepatic and intravenous administration of adriamycin--a comparative pharmacokinetic study in patients with malignant liver tumours.

Authors:  S Eksborg; B J Cedermark; H S Strandler
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

7.  A phase I and pharmacokinetic comparison of hepatic arterial and peripheral vein infusions of bisantrene for liver cancer.

Authors:  G R Weiss; M Hersh; J G Kuhn; T M Ludden; D D von Hoff; D L Kisner; T E Pirtle
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

8.  Transcatheter hepatic arterial chemoembolization using epirubicin-lipiodol: experimental and pharmacological evaluation.

Authors:  S Kobayashi; Y Narimatsu; K Ogawa; S Hashimoto; S Nakatsuka; H Miura; H Ohzono; W J Ka; K Ido; K Hiramatsu
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

9.  Phase II study of hepatic artery infusion with 5-fluorouracil, adriamycin, and mitomycin C (FAM) in liver metastases from colorectal carcinoma.

Authors:  J Wils; J Schlangen; A Naus
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

10.  The effects of cimetidine upon the plasma pharmacokinetics of doxorubicin in rabbits.

Authors:  D E Brenner; J C Collins; K R Hande
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.